ORCHARD THERAPEUTICS PLC.

In News

Orchard turns to layoffs in cutting gene therapy research - BioPharma Dive

BioPharma Dive - Mar 30, 2022

Slaughter and May is advising Orchard Therapeutics on its recommended cash acquisition by Kyowa Kirin - Slaughter and May

Slaughter and May - Oct 05, 2023

GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics - GSK

GSK - Apr 12, 2018

Kyowa Kirin acquires Orchard Therapeutics for $477.6m - Pharmaceutical Technology

Pharmaceutical Technology - Jan 25, 2024

Why Orchard Therapeutics Stock Is Soaring Today - The Motley Fool

The Motley Fool - Oct 05, 2023

Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome - Yahoo Finance UK

Yahoo Finance UK - Jul 07, 2025

Massive restructuring shutters under-construction gene therapy plant in East Bay, Peninsula R&D site - The Business Journals

The Business Journals - May 08, 2020

Orchard Therapeutics plc (NASDAQ: ORTX) - Share Price - intelligentinvestor.com.au

intelligentinvestor.com.au - Dec 28, 2024

Orchard Therapeutics hires ex-PTC executive Mark Rothera as new CEO - Fierce Biotech

Fierce Biotech - Aug 10, 2017

Tiny U.K. Biotech Takes On Glaxo’s $730,000 Gene Therapy - Bloomberg.com

Bloomberg.com - Mar 06, 2018

Orchard sets out to sell world’s priciest gene therapy - BioPharma Dive

BioPharma Dive - Mar 20, 2024

Rare stem cell success gives young girl life outside the bubble - Capitol Weekly

Capitol Weekly - Dec 20, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment